Current pharmacotherapeutic options for primary dyslipidemia in adults
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1604687
Abstract: ABSTRACT Introduction: Atherosclerotic cardiovascular disease (ASCVD) and its clinical manifestations, remain a leading cause of death and disability worldwide. One of the major risk factors of ASCVD is dyslipidemia and all the available guidelines suggest… read more here.
Keywords: primary dyslipidemia; current pharmacotherapeutic; treatment; pharmacotherapeutic options ... See more keywords
Treatment options in primary hyperoxaluria Type I
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2017.1298439
Abstract: ABSTRACT Introduction: Primary Hyperoxaluria Type I (PH1) is due to the deficiency of liver peroxisomal alanine:glyoxylate aminotransferase (AGT). The disease manifests as calcium oxalate stones that deposit at first in the kidneys and then in… read more here.
Keywords: primary hyperoxaluria; treatment; treatment options; ph1 ... See more keywords